Self-Reported Alcohol, Tobacco, and Cannabis Use During COVID-19 Lockdown Measures: Results from a Web-Based Survey
Overview
Authors
Affiliations
Background: The outbreak of coronavirus disease 19 (COVID-19) has led to measures of social distancing and quarantine worldwide. This stressful period may lead to psychological problems, including increases in substance use.
Objective: To investigate changes in alcohol, tobacco, and cannabis consumption before and during COVID-19 lockdown and motives for these changes in substance use.
Method: A web-based survey was filled out by an unselected population during the social distancing measures of the COVID-19 pandemic in Belgium that assessed changes in alcohol, tobacco, and cannabis consumption in the period before and during the COVID-19 lockdown and also asked about reasons for change.
Results: A total of 3,632 respondents (mean age 42.1 ± 14.6 years; 70% female) filled out the survey. Overall, respondents reported consuming more alcohol (d = 0.21) and smoking more cigarettes (d = 0.13) than before the COVID-19 pandemic (both p < 0.001), while no significant changes in the consumption of cannabis were noted. The odds of consuming more alcohol during the lockdown were associated with younger age (OR = 0.981, p < 0.001), more children at home (OR = 1.220, p < 0.001), non-healthcare workers (p < 0.001), and being technically unemployed related to COVID-19 (p = 0.037). The odds of smoking more cigarettes during the lockdown were associated with younger age (OR = 0.988, p = 0.027), current living situation (p < 0.001), lower education (p = 0.015), and working situation related to COVID-19 (p = 0.018). Boredom, lack of social contacts, loss of daily structure, reward after a hard-working day, loneliness, and conviviality were the main reasons for consuming more of the various substances.
Conclusions: During the lockdown, individuals consumed slightly more alcohol and smoked marginally more cigarettes compared to the period before the lockdown. Further research focussing on follow-up of individuals at risk may be useful to provide appropriate care in post-COVID times.
Asta F, Minardi V, Contoli B, Possenti V, Casigliani V, Masocco M BMC Public Health. 2025; 25(1):799.
PMID: 40016716 PMC: 11869655. DOI: 10.1186/s12889-025-22062-2.
Merlo A, Koyun A, Hendriksen P, Garssen J, Bruce G, Stock A Hum Psychopharmacol. 2025; 40(2):e70000.
PMID: 39887587 PMC: 11780482. DOI: 10.1002/hup.70000.
Yamamoto H, Shirasawa M, Naoki K Int J Clin Oncol. 2025; 30(2):199-209.
PMID: 39821472 DOI: 10.1007/s10147-025-02695-4.
Cerrai S, Carreras G, Monti F, Stival C, Lugo A, Bosetti C J Epidemiol. 2024; 35(2):63-70.
PMID: 39694502 PMC: 11706678. DOI: 10.2188/jea.JE20230340.
Papatriantafyllou E, Efthymiou D, Felekkis K, Solmi M, Correll C, Thompson T J Clin Med. 2024; 13(18).
PMID: 39336883 PMC: 11432565. DOI: 10.3390/jcm13185395.